The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Corbus Pharmaceuticals Holdings Inc shares valued at $317,407 were sold by Cohen Yuval on Oct 24 ’25. At $17.01 per share, Cohen Yuval sold 18,660 shares. The insider’s holdings dropped to 138,187 shares worth approximately $1.34 million following the completion of this transaction.
Also, Cohen Yuval sold 8,973 shares, netting a total of over 153,797 in proceeds. Following the sale of shares at $17.14 each, the insider now holds 138,187 shares.
Before that, Moran Sean F. had sold 12,981 shares from its account. In a trade valued at $220,937, the Chief Financial Officer traded Corbus Pharmaceuticals Holdings Inc shares for $17.02 each. Upon closing the transaction, the insider’s holdings decreased to 12,981 shares, worth approximately $0.71 million.
Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in late February. As of December 02, 2024, Piper Sandler has initiated its “an Overweight” rating for CRBP. Earlier on July 30, 2024, Wedbush initiated its rating. Their recommendation was “an Outperform” for CRBP stock.
Analyzing CRBP Stock Performance
On last trading session, Corbus Pharmaceuticals Holdings Inc [NASDAQ: CRBP] plunged -5.65% to $9.68. The stock’s lowest price that day was $9.7, but it reached a high of $11.6399 in the same session. During the last five days, there has been a drop of approximately -9.45%. Over the course of the year, Corbus Pharmaceuticals Holdings Inc shares have dropped approximately -36.48%. Shares of the company reached a 52-week high of $20.56 on 10/20/25 and a 52-week low of $4.64 on 04/07/25.
Support And Resistance Levels for Corbus Pharmaceuticals Holdings Inc (CRBP)
According to the 24-hour chart, there is a support level at 8.87, which, if violated, would cause prices to drop to 8.05. In the upper region, resistance lies at 11.07. The next price resistance is at 12.45. RSI (Relative Strength Index) is 33.79 on the 14-day chart, showing neutral technical sentiment.
Is Corbus Pharmaceuticals Holdings Inc subject to short interest?
Stocks of Corbus Pharmaceuticals Holdings Inc saw a sharp steep in short interest on 2025-11-28 dropping by 31946.0 shares to 1.02 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 1.05 million shares. A decline of -3.14% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.04 of the overall float, the days-to-cover ratio (short ratio) decline to 2.04.
Which companies own the most shares of Corbus Pharmaceuticals Holdings Inc (CRBP)?
In terms of Corbus Pharmaceuticals Holdings Inc share price expectations, FactSet research, analysts set an average price target of 40 in the next 12 months, up nearly 289.86% from the previous closing price of $10.26. Analysts anticipate Corbus Pharmaceuticals Holdings Inc stock to reach 51 by 2025, with the lowest price target being 39. In spite of this, 4 analysts ranked Corbus Pharmaceuticals Holdings Inc stock as Buy at the end of 2025. On July 22, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and resumed coverage with a $80.
